CSL is one of three Tier 1 plasma therapy companies that benefit from an oligopoly in a highly consolidated market. All the players are vertically integrated as plasma sourcing is a key constraint in production. The plasma sourcing market is currently in short supply, however, CSL is well positioned having invested significantly in plasma collection centers, owning roughly 30% of collection centers globally.
CSL is investing in both physical capacity and R&D, leaving it well positioned to take advantage of growth opportunities in the key immunoglobulins market.
Areas of the plasma industry could be replaced by newer therapies, which would leave CSL overinvested in plasma collection and fractionation capacity that will be hard to repurpose.
|
Metric
|
CSL
|
PFE
|
4502
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.03 | 20.79 | 16.04 |
Price/Book Value | 5.38 | 1.83 | 0.85 |
Price/Sales | 6.25 | 2.88 | 1.52 |
Price/Cash Flow | 33.21 | 21.00 | 7.61 |
|
Metric
|
CSL
|
PFE
|
4502
|
|---|---|---|---|
Quick Ratio | 0.87 | 0.51 | 0.66 |
Current Ratio | 2.18 | 0.86 | 1.26 |
Interest Coverage | 8.01 | −0.88 | 1.21 |
|
Metric
|
CSL
|
PFE
|
4502
|
|---|---|---|---|
Return on Assets (Normalized) | 7.82% | 3.50% | 2.91% |
Return on Equity (Normalized) | 17.33% | 8.28% | 6.11% |
Return on Invested Capital (Normalized) | 10.52% | 5.39% | 4.29% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Wydvdjyh | Nhbx | $516.0 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Sxcfrgq | Lqqdjp | $117.1 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Bvlxtrgm | Sqltqqg | $111.8 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Gchrhqqx | Nwvgkk | $34.6 Bil | |||
| argenx SE ADR
ARGX
| Dmjqcyw | Vjsg | $33.0 Bil | |||
| BioNTech SE ADR
BNTX
| Knhsvjg | Ppqw | $28.5 Bil | |||
| Moderna Inc
MRNA
| Zbsqfncq | Vtl | $23.5 Bil | |||
| United Therapeutics Corp
UTHR
| Ytpstnscz | Sfb | $15.6 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Hpphnptxn | Ztscgc | $13.0 Bil | |||
| Incyte Corp
INCY
| Jwccfrjfy | Jffyyh | $12.9 Bil |
United States